Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
Black or African American
/ statistics & numerical data
Aged
Aged, 80 and over
Antineoplastic Agents
/ therapeutic use
Carcinoma, Non-Small-Cell Lung
/ mortality
Healthcare Disparities
Humans
Lung Neoplasms
/ mortality
Male
Medicare
/ statistics & numerical data
Neoplasm Staging
Pneumonectomy
/ statistics & numerical data
Radiotherapy
/ statistics & numerical data
SEER Program
/ statistics & numerical data
United States
/ epidemiology
United States Department of Veterans Affairs
/ statistics & numerical data
Veterans
/ statistics & numerical data
White People
/ statistics & numerical data
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
20
03
2019
revised:
28
05
2019
accepted:
07
10
2019
pubmed:
19
10
2019
medline:
12
1
2021
entrez:
19
10
2019
Statut:
ppublish
Résumé
Surgery is the preferred treatment for stage I non-small cell lung cancer (NSCLC), with radiation reserved for those not receiving surgery. Previous studies have shown lower rates of surgery among Blacks with stage I NSCLC than among Whites. Black and White men ages ≥65 years with stage I NSCLC diagnosed between 2001 and 2009 were identified in the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and Veterans Affairs (VA) cancer registry. Logistic regression and Cox proportional hazards models were used to examine associations between race, treatment, and survival. Among the patients in the VA ( Among VA and SEER-Medicare patients, Blacks were less likely to get surgical treatment. Blacks and Whites had similar survival outcomes when accounting for treatment. This supports the hypothesis that equal treatment correlates with equal outcomes and emphasizes the need to understand multilevel predictors of lung cancer treatment disparities.
Sections du résumé
BACKGROUND
Surgery is the preferred treatment for stage I non-small cell lung cancer (NSCLC), with radiation reserved for those not receiving surgery. Previous studies have shown lower rates of surgery among Blacks with stage I NSCLC than among Whites.
METHODS
Black and White men ages ≥65 years with stage I NSCLC diagnosed between 2001 and 2009 were identified in the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and Veterans Affairs (VA) cancer registry. Logistic regression and Cox proportional hazards models were used to examine associations between race, treatment, and survival.
RESULTS
Among the patients in the VA (
CONCLUSIONS
Among VA and SEER-Medicare patients, Blacks were less likely to get surgical treatment. Blacks and Whites had similar survival outcomes when accounting for treatment.
IMPACT
This supports the hypothesis that equal treatment correlates with equal outcomes and emphasizes the need to understand multilevel predictors of lung cancer treatment disparities.
Identifiants
pubmed: 31624076
pii: 1055-9965.EPI-19-0245
doi: 10.1158/1055-9965.EPI-19-0245
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
112-118Informations de copyright
©2019 American Association for Cancer Research.